Effectiveness of out-of-pocket cost COMmunication and financial navigation (CostCOM) in cancer patients: Study protocol for ECOG-ACRIN EAQ222CD.
Gelareh Sadigh, Fenghai Duan, Ilana F Gareen...
https://pubmed.ncbi.nlm.nih.gov/40147544/Actively Recruiting
Led by ECOG-ACRIN Cancer Research Group · Updated on 2026-10-29
760
Participants Needed
391
Research Sites
4 weeks
Total Duration
Researchers are evaluating the impact of the Cost Communication and Financial Navigation CostCOM intervention on adherence to cancer care and financial burden among patients with malignant solid tumors. This study compares the effects of enhanced usual care and the CostCOM program, which offers financial counseling and resource connections to reduce financial barriers and stress. The study aims to assess cost-related non-adherence, financial hardship, worry, quality of life, and satisfaction with care over 12 months. Participants are randomly assigned to one of two groups one group receives a brochure about financial navigation services, while the other group receives usual financial care plus CostCOM counseling sessions lasting about one hour within 30 days of enrollment and again at 3, 6, and 12 months. Non-patient participants involved in the study complete surveys and participate in in-depth interviews between 15 and 39 months after the first patient enrollment. During the study, patients complete surveys at baseline and at 3, 6, and 12 months to report on financial worry, quality of life, and satisfaction with care. Researchers track adherence to cancer treatment and financial outcomes over one year. Non-patient participants contribute by completing surveys and interviews to provide insights into the use and experience of the CostCOM intervention. The total participation time extends up to 12 months for patients and up to 39 months for non-patient participants.
CONDITIONS
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
ECOG-ACRIN Cancer Research Group
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | CostCOM intervention | Enhanced usual care |
|---|---|---|
| What it is | An intervention combining personalized out‑of‑pocket cost communication, financial counseling, and navigation sessions delivered remotely to support patients | Enhanced usual care includes a brochure describing financial navigation services provided by Patient Advocate Foundation |
| Role in trial | Experimental arm receiving the active CostCOM financial navigation intervention | Active comparator arm receiving enhanced usual care via informational brochure |
| Primary use | To reduce cost‑related non‑adherence to cancer care and financial hardship via active financial navigation | Provide awareness of financial navigation resources through educational brochure |
| How it is given or performed | Delivered remotely via four counseling sessions incorporating cost communication, navigation, and counseling at baseline, 3, 6, and 12 months | Single educational brochure provided at enrollment describing existing financial navigation services |
| Evidence status | Effectiveness under investigation; preliminary pilot study has shown feasibility and some uptake of assistance applications | Current standard practice extrapolated from informational materials; efficacy not established |
| Important limitations | Evidence on effectiveness is limited to feasibility from a small pilot; full efficacy and impact outcomes are pending from the ongoing randomized trial | Comparator provides only passive information; may not actively address patient financial navigation needs |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened to determine if they meet the eligibility requirements for the trial.
1 screening visit
Duration - 12 months
Participants are randomly assigned to receive either a brochure about financial navigation services or usual care plus CostCOM financial counseling sessions at enrollment and at 3, 6, and 12 months.
Counseling sessions at enrollment, 3, 6, and 12 months
Duration - 15 to 39 months
Non-patient participants complete surveys and in-depth interviews between 15 and 39 months after the first patient enrollment to provide feedback on the CostCOM intervention.
1 to 2 visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Gelareh Sadigh, Fenghai Duan, Ilana F Gareen...
https://pubmed.ncbi.nlm.nih.gov/40147544/ECOG-ACRIN Cancer Research Group
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor